Primary tabs

Using TBK1, a Novel Molecule Which Controls the Adjuvancticity of DNA Vaccines, to Improve DNA Vaccine Immunogencity against Malaria

DNA vaccines, which can elicit killer T-cell response, have thus far failed to elicit reliable, strong immune response in humans. Cevayir Coban of Osaka University in Japan will use newly identified intracellular signaling molecules as components of DNA vaccines against malaria.

Grant ID
OPP51701
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Principal Investigator
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False